Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JUAN C GARZA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1669449971
CMS profile
165973
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$462.87

34 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $432.88 33
Education $29.99 1

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JUAN C GARZA

NPI 1669449971 · CMS profile ID 165973

Allopathic & Osteopathic Physicians / Family Medicine

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1669449971?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JUAN C GARZA, NPI 1669449971, CMS profile ID 165973. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669449971?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JUAN C GARZA, NPI 1669449971, CMS profile ID 165973. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669449971?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JUAN C GARZA, NPI 1669449971, CMS profile ID 165973, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1669449971?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

34 matching records · $462.87 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 34 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–34 of 34.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Allergan, Inc. $9.0612/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766867 CMS
AstraZeneca Pharmaceuticals LP $13.0411/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736132441 CMS
Novo Nordisk Inc $15.3010/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744944913 CMS
Novo Nordisk Inc $19.4110/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744930581 CMS
Novo Nordisk Inc $14.2409/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744917249 CMS
Novo Nordisk Inc $1.9109/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744917251 CMS
Allergan, Inc. $21.6809/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766863 CMS
Allergan, Inc. $10.0909/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766865 CMS
AstraZeneca Pharmaceuticals LP $17.2909/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736173379 CMS
Novo Nordisk Inc $12.0409/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744898599 CMS
Novo Nordisk Inc $13.3408/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744847389 CMS
Allergan, Inc. $13.5008/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766861 CMS
PFIZER INC. $6.1708/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743758333 CMS
Teva Pharmaceuticals USA, Inc. $15.5507/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749457177 CMS
AstraZeneca Pharmaceuticals LP $14.6406/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735810801 CMS
AstraZeneca Pharmaceuticals LP $13.0806/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735815347 CMS
Merck Sharp & Dohme Corporation $13.1806/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747724193 CMS
Allergan, Inc. $29.9905/20/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766859 CMS
Novo Nordisk Inc $14.3005/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744716401 CMS
Novo Nordisk Inc $9.3704/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744671771 CMS
Allergan, Inc. $22.9304/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766857 CMS
Novo Nordisk Inc $15.9804/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744663611 CMS
Genentech USA, Inc. $15.2103/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743038515 CMS
PFIZER INC. $9.5702/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743681351 CMS
PFIZER INC. $6.6602/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743681205 CMS
Allergan, Inc. $2.4102/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766855 CMS
Amarin Pharma Inc. $14.2802/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739939509 CMS
Novo Nordisk Inc $9.8702/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744588075 CMS
PFIZER INC. $1.3902/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743681209 CMS
AstraZeneca Pharmaceuticals LP $13.9002/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735953161 CMS
Allergan, Inc. $12.6701/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723766853 CMS
AstraZeneca Pharmaceuticals LP $39.2401/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736299499 CMS
PFIZER INC. $6.4501/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743659613 CMS
Novo Nordisk Inc $15.1301/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744577705 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $697.42 45
PY2020 $462.87 34
PY2021 $606.41 45
PY2022 $1,514.63 68
PY2023 $1,566.78 94
PY2024 $1,681.91 93
PY2025 $1,387.30 78

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $43,373.43 14
PY2024 Principal investigator $171,802.76 70
PY2023 Recipient $23,812.92 7
PY2023 Principal investigator $383,116.06 124
PY2022 Principal investigator $624,521.08 179
PY2021 Principal investigator $663,885.83 360
PY2020 Principal investigator $248,213.43 166
PY2019 Principal investigator $403,386.63 210

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

166 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $5,491.94 12/22/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4352 No dispute reported 06/30/2026 742420195
Principal investigator 1 Novo Nordisk AS $1,144.12 12/22/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4321 No dispute reported 06/30/2026 742420201
Principal investigator 1 Novo Nordisk AS $2,755.03 12/22/2020 Non-covered Recipient Entity
VIP TRIALS LLC
EX9536-4388 No dispute reported 06/30/2026 742420205
Principal investigator 1 Novo Nordisk AS $229.84 12/22/2020 Non-covered Recipient Entity
VIP TRIALS LLC
EX9536-4388 No dispute reported 06/30/2026 742420207
Principal investigator 1 Novo Nordisk AS $500.00 12/22/2020 Non-covered Recipient Entity
VIP TRIALS LLC
EX9536-4388 No dispute reported 06/30/2026 742420209
Principal investigator 1 Novo Nordisk AS $18.00 12/21/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4321 No dispute reported 06/30/2026 822169435
Principal investigator 1 Novo Nordisk AS $50.00 12/18/2020 Non-covered Recipient Entity
VIP TRIALS LLC
EX9536-4388 No dispute reported 06/30/2026 822171273
Principal investigator 1 PFIZER INC. $5,768.43 12/17/2020 Non-covered Recipient Entity
VIP Trials LLC
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 742877313
Principal investigator 1 AbbVie Inc. $26,043.50 12/14/2020 Non-covered Recipient Entity
VIP TRIALS
M16-100 No dispute reported 06/30/2026 721200367
Principal investigator 1 Biohaven Pharmaceuticals, Inc. $245.75 12/11/2020 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention No dispute reported 06/30/2026 748986599
Principal investigator 1 Novo Nordisk AS $36.00 12/11/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4352 No dispute reported 06/30/2026 822165817
Principal investigator 1 Novo Nordisk AS $82.00 12/09/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4352 No dispute reported 06/30/2026 822165815
Principal investigator 1 Novo Nordisk AS $7,094.27 11/30/2020 Non-covered Recipient Entity
VIP TRIALS LLC
EX9536-4388 No dispute reported 06/30/2026 742420203
Principal investigator 1 Novo Nordisk AS $6,411.10 11/24/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4352 No dispute reported 06/30/2026 742420193
Principal investigator 1 Novo Nordisk AS $233.29 11/24/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4321 No dispute reported 06/30/2026 742420197
Principal investigator 1 Novo Nordisk AS $278.69 11/24/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4321 No dispute reported 06/30/2026 742420199
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420023
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420025
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420027
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420029
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420031
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420033
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420035
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420037
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420039
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420041
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420043
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420045
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420047
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420049
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420051
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420053
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420055
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420057
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420059
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420061
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420063
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420065
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420067
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420069
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420071
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420073
Principal investigator 1 Novo Nordisk AS $24.95 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420075
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420077
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420079
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420081
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420083
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420085
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420087
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420089
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420091
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420093
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420095
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420097
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420099
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420101
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420103
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420105
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420107
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420109
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420111
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420113
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420115
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420117
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420119
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420121
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420123
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420125
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420127
Principal investigator 1 Novo Nordisk AS $34.14 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420129
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420131
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420133
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420135
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420137
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420139
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420141
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420143
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420145
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420147
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420149
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420151
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420153
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420155
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420157
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420159
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420161
Principal investigator 1 Novo Nordisk AS $19.50 11/05/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420163
Principal investigator 1 PFIZER INC. $7,268.43 10/30/2020 Non-covered Recipient Entity
VIP Trials LLC
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 742875401
Principal investigator 1 Novo Nordisk AS $1,144.12 10/29/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420171
Principal investigator 1 Novo Nordisk AS $7,102.43 10/29/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742420183
Principal investigator 1 Novo Nordisk AS $500.00 10/29/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742420185
Principal investigator 1 Novo Nordisk AS $200.00 10/29/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742420187
Principal investigator 1 Novo Nordisk AS $9,397.18 10/27/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420181
Principal investigator 1 Novo Nordisk AS $41.06 10/19/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420017
Principal investigator 1 Novo Nordisk AS $10,141.91 09/24/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420175
Principal investigator 1 Novo Nordisk AS $500.00 09/24/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420177
Principal investigator 1 Novo Nordisk AS $350.00 09/24/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420179
Principal investigator 1 Novo Nordisk AS $82.12 09/24/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420189
Principal investigator 1 Novo Nordisk AS $2,397.37 09/22/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420165
Principal investigator 1 Novo Nordisk AS $1,000.00 09/22/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420167
Principal investigator 1 Novo Nordisk AS $1,137.20 09/22/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420169
Principal investigator 1 Novo Nordisk AS $123.18 09/16/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420191
Principal investigator 1 Novo Nordisk AS $11,340.05 08/31/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420173
Principal investigator 1 Novo Nordisk AS $82.12 08/28/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420013
Principal investigator 1 Novo Nordisk AS $9.99 08/19/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420009
Principal investigator 1 Novo Nordisk AS $45.56 08/19/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420011
Principal investigator 1 Novo Nordisk AS $123.18 08/13/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420015
Principal investigator 1 Novo Nordisk AS $27.96 08/12/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420003
Principal investigator 1 Novo Nordisk AS $82.12 08/07/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420007
Principal investigator 1 Novo Nordisk AS $82.12 08/04/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420005
Principal investigator 1 Novo Nordisk AS $27.96 07/21/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742420021
Principal investigator 1 Novo Nordisk AS $123.18 07/09/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420019
Principal investigator 1 AbbVie Inc. $4,322.65 06/30/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721172787
Principal investigator 1 Novo Nordisk AS $12.75 06/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419989
Principal investigator 1 Novo Nordisk AS $124.95 06/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419991
Principal investigator 1 Novo Nordisk AS $22.50 06/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419993
Principal investigator 1 Novo Nordisk AS $150.00 06/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419995
Principal investigator 1 Novo Nordisk AS $16.25 06/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419997
Principal investigator 1 Novo Nordisk AS $24.50 06/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419999
Principal investigator 1 Novo Nordisk AS $90.00 06/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742420001
Principal investigator 1 Novo Nordisk AS $200.00 06/25/2020 Non-covered Recipient Entity
VIP TRIALS LLC
EX9536-4388 No dispute reported 06/30/2026 742420215
Principal investigator 1 Novo Nordisk AS $2,234.20 06/23/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4352 No dispute reported 06/30/2026 742420211
Principal investigator 1 Novo Nordisk AS $6,670.91 06/23/2020 Non-covered Recipient Entity
VIP TRIALS LLC
EX9536-4388 No dispute reported 06/30/2026 742420213
Principal investigator 1 Novo Nordisk AS $506.24 06/23/2020 Non-covered Recipient Entity
VIP TRIALS LLC
NN9535-4321 No dispute reported 06/30/2026 742420217
Principal investigator 1 AbbVie Inc. $2,874.45 05/28/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721167691
Principal investigator 1 Novo Nordisk AS $2,459.92 05/28/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419943
Principal investigator 1 Novo Nordisk AS $200.00 05/28/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419963
Principal investigator 1 Novo Nordisk AS $2,938.79 05/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419961
Principal investigator 1 PFIZER INC. $5,768.43 05/16/2020 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 742879411
Principal investigator 1 AbbVie Inc. $455.00 04/30/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721163077
Principal investigator 1 Novo Nordisk AS $2,478.94 04/30/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419941
Principal investigator 1 Novo Nordisk AS $8,714.52 04/23/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419959
Principal investigator 1 Novo Nordisk AS $23.06 04/20/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419979
Principal investigator 1 PFIZER INC. $5,768.43 04/02/2020 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 742878713
Principal investigator 1 Novo Nordisk AS $69.18 04/01/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419977
Principal investigator 1 AbbVie Inc. $3,269.30 03/31/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721159131
Principal investigator 1 Novo Nordisk AS $1,518.72 03/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419951
Principal investigator 1 Novo Nordisk AS $10,712.47 03/26/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419957
Principal investigator 1 Novo Nordisk AS $7,751.78 03/24/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419937
Principal investigator 1 Novo Nordisk AS $600.00 03/24/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419939
Principal investigator 1 PFIZER INC. $15,500.00 03/18/2020 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B RANDOMIZED DOUBLEBLIND PARALLELGROUP PLACEBOCONTROLLED STUDY WITH AN OPEN LABEL EXTENSION TO EVALUATE THE SAFETY AND EFFICACY OF PF06826647 IN PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 742946721
Principal investigator 1 AbbVie Inc. $9,120.55 03/11/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721155381
Principal investigator 1 AbbVie Inc. $1,790.10 03/09/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721154939
Principal investigator 1 AbbVie Inc. $1,425.00 03/09/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721154941
Principal investigator 1 AbbVie Inc. $2,937.60 03/09/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721154943
Principal investigator 1 Novo Nordisk AS $69.18 02/28/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419975
Principal investigator 1 PFIZER INC. $3,186.18 02/28/2020 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 949010616
Principal investigator 1 Novo Nordisk AS $5,934.06 02/27/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419935
Principal investigator 1 Novo Nordisk AS $2,791.66 02/27/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419955
Principal investigator 1 Novo Nordisk AS $1,000.00 02/25/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419947
Principal investigator 1 Novo Nordisk AS $450.00 02/25/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419949
Principal investigator 1 Novo Nordisk AS $46.12 02/19/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419969
Principal investigator 1 Novo Nordisk AS $23.06 02/13/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419973
Principal investigator 1 Novo Nordisk AS $23.06 02/12/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419971
Principal investigator 1 PFIZER INC. $7,713.75 02/12/2020 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 949010613
Principal investigator 1 Novo Nordisk AS $69.18 02/07/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419965
Principal investigator 1 PFIZER INC. $10,500.00 02/07/2020 Non-covered Recipient Entity
Victorium Clinical Research
A PHASE 2B MULTICENTER RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED DOSERANGING STUDY TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS OF PF06480605 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS No dispute reported 06/30/2026 742879025
Principal investigator 1 Novo Nordisk AS $69.18 02/04/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419967
Principal investigator 1 AbbVie Inc. $1,156.60 01/30/2020 Non-covered Recipient Entity
VICTORIUM CLINICAL RESEARCH LTD
M16-100 No dispute reported 06/30/2026 721147705
Principal investigator 1 Novo Nordisk AS $1,253.24 01/28/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419945
Principal investigator 1 Novo Nordisk AS $887.39 01/28/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419953
Principal investigator 1 Novo Nordisk AS $23.06 01/23/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4321 No dispute reported 06/30/2026 742419987
Principal investigator 1 Novo Nordisk AS $24.99 01/22/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419981
Principal investigator 1 Novo Nordisk AS $500.00 01/14/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419933
Principal investigator 1 Novo Nordisk AS $24.99 01/10/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
EX9536-4388 No dispute reported 06/30/2026 742419983
Principal investigator 1 Novo Nordisk AS $138.36 01/10/2020 Non-covered Recipient Entity
PRIMECARE MEDICAL GROUP
NN9535-4352 No dispute reported 06/30/2026 742419985